Cc. Campi et Gd. Clarke, EFFECTS OF HIGHLY SELECTIVE KAPPA-OPIOID AGONISTS ON EEG POWER SPECTRA AND BEHAVIORAL-CORRELATES IN CONSCIOUS RATS, Pharmacology, biochemistry and behavior, 51(4), 1995, pp. 611-616
The present study compares the electroencephalographic (EEG) and behav
ioural effects of highly selective kappa-opioid agonists, spiradoline
(U62066), enadoline (CI-977), BRL 52656, and BRL 53001, after SC admin
istration to conscious rats. All compounds caused a distinctive dose-
and time-related EEG effect and behavioural profile. The EEG power spe
ctra (PS) of treated animals were characterised by power reduction ind
icative of CNS activation and an unusual spectral peak at 4-7 Hz, comp
ared to controls. Behaviourally, however, the animals appeared to be s
edated, with a reduction of locomotor activity, loss of postural tone,
ataxia, and unusual hyperreactivity. The compounds differed in their
liability to produce these CNS effects, with kappa-opioid analgesics s
uch as enadoline and BRL 53001 showing a reduced propensity at equival
ent antinociceptive doses. Where tested, these effects were inhibited
by the nonselective opioid antagonist naloxone. The non-brain penetrat
ing kappa-opioid agonist, BRL 52974, failed to produce alterations in
EEG PS or behaviour, up to a dose of 10 mg/kg, indicating that the eff
ects depend on activation of centrally located kappa-receptors.